Skip to main content

Pre IVF Evaluation of the Infertile Woman

  • Chapter
  • First Online:
In Vitro Fertilization

Abstract

Patients presenting for infertility have the advantage of receiving a complete preconception evaluation including recommended antenatal screening, appropriate referrals to specialists as necessary, and optimizing health for pregnancy. Testing to determine optimal treatment includes, at a minimum, ovarian reserve screening, uterine cavity evaluation, and semen analysis. Balancing psychological, emotional, and financial pressures with realistic expectations in a supportive physician–patient relationship is essential in guiding treatment. While not all infertile women require IVF to achieve pregnancy, the clinical algorithm remains the same as for those who ultimately proceed to IVF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2009 Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta, GA: US Department of Health and Human Services; 2011. http://www.cdc.gov/art/ART2009/PDF/ART_2009_Full.pdf. Accessed 2 Jan 2012.

  2. Olive DL, Lindheim SR, Pritts EA. Endometriosis and infertility: what do we do for each stage? Curr Womens Health Rep. 2003;3(5):389–94.

    PubMed  Google Scholar 

  3. Senapati S, Barnhart K. Managing endometriosis-associated infertility. Clin Obstet Gynecol. 2011;54(4):720–6.

    Article  PubMed  Google Scholar 

  4. NIH Consensus Statement on Celiac Disease. NIH Consens State Sci Statements. 2004; 21(1):1–22. http://consensus.nih.gov/2004/2004CeliacDisease118html.htm. Accessed 16 Mar 2012.

  5. American Academy of Pediatrics Committee on Fetus and Newborn and the American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Antepartum care. Guidelines for perinatal care. 6th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2007.

    Google Scholar 

  6. American College of Obstetricians and Gynecologists. Obesity in pregnancy. ACOG Committee opinion no. 315. Obstet Gynecol. 2005;106:671–5 (reaffirmed 2008).

    Article  Google Scholar 

  7. Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23(4):421–39.http://web.ebscohost.com.ezp-prod1.hul.harvard.edu/ehost/pdfviewer/pdfviewer?sid=fa6e24c2-0db0-4fcc-9049-cec786f4bbc6%40sessionmgr4&vid=2&hid=13. Accessed 2 Jan 2012.

    Article  PubMed  Google Scholar 

  8. Moragianni VA, Jones SML, Ryley DA. The effect of BMI on outcomes of first assisted reproductive technology cycles. Fertil Steril. 2012;98:102–8.

    Article  PubMed  Google Scholar 

  9. Shah DK, Missmer SA, Berry KF, Racowsky C, Ginsburg ES. Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol. 2011;118(1):63–70.

    Article  PubMed  Google Scholar 

  10. Depalo R, Garruti G, Totaro I, et al. Oocyte morphological abnormalities in overweight women undergoing in vitro fertilization cycles. Gynecol Endocrinol. 2011;27(11):880–4.

    Article  PubMed  CAS  Google Scholar 

  11. American College of Obstetricians and Gynecologists. Preconception and prenatal carrier screening for genetic diseases in individuals of eastern European Jewish descent. ACOG Committee opinion no. 442. Obstet Gynecol. 2009;114(4):950–3.

    Article  Google Scholar 

  12. Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS data brief, no 76. Hyattsville, MD: National Center for Health Statistics. 2011. http://www.cdc.gov/nchs/data/databriefs/db76.htm. Accessed 1 Feb 2012.

  13. Coutifaris C, Mayers ER, Guzick DS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril. 2004;82:1264–72.

    Article  PubMed  Google Scholar 

  14. Grimes DA. Validity of the postcoital test. Am J Obstet Gynecol. 1995;172:1327.

    Article  PubMed  CAS  Google Scholar 

  15. Bayer SR, Alper MM, Penzias AS, editors. Boston IVF handbook of infertility. 3rd ed. New York: Informa Healthcare; 2011.

    Google Scholar 

  16. Fritz MA, Speroff L, editors. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011.

    Google Scholar 

  17. Verhagen TE, Hendriks DJ, Bancsi LF, Mol BW, Broekmans FJ. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Update. 2008;14(2):95–100.

    Article  PubMed  CAS  Google Scholar 

  18. van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril. 2003;79(3):482–8.

    Article  PubMed  Google Scholar 

  19. Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod. 2004;19(4):893–8.

    Article  PubMed  CAS  Google Scholar 

  20. Toner JP. Age  =  egg quality, FSH level  =  egg quantity. Fertil Steril. 2003;79(3):491.

    Article  PubMed  Google Scholar 

  21. Yanushpolsky EH, Hurwitz S, Tikh E, Racowsky C. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age. Fertil Steril. 2003;80(1):111–5.

    Article  PubMed  Google Scholar 

  22. Hofmann GE, Danforth DR, Seifer DB. Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril. 1998;69(3):474–7.

    Article  PubMed  CAS  Google Scholar 

  23. Urbancsek J, Hauzman E, Klinga K, Rabe T, Papp Z, Strowitzki T. Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome. Fertil Steril. 2005;83(2):341–8.

    Article  PubMed  CAS  Google Scholar 

  24. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999;14(2):409–15.

    Article  PubMed  CAS  Google Scholar 

  25. Fanchin R, de Ziegler D, Olivennes F, et al. Exogeneous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting “poor responder” in in-vitro fertilization. Hum Reprod. 1994;9:1607–11.

    PubMed  CAS  Google Scholar 

  26. Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril. 2003;80(2):350–5.

    Article  PubMed  Google Scholar 

  27. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril. 1998;69(3):505–10.

    Article  PubMed  CAS  Google Scholar 

  28. Erdem M, Erdem A, Guler I, Atmaca S. Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility. Fertil Steril. 2008;90(2):360–6.

    Article  PubMed  Google Scholar 

  29. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1–9.

    Article  PubMed  CAS  Google Scholar 

  30. van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17(12):3065–71.

    Article  PubMed  Google Scholar 

  31. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747–50.

    Article  PubMed  CAS  Google Scholar 

  32. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685–718.

    Article  PubMed  CAS  Google Scholar 

  33. Pittaway DE, Winfield AC, Maxson W, et al. Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis. Am J Obstet Gynecol. 1983;147:623–6.

    PubMed  CAS  Google Scholar 

  34. Practice Committee of the American Society for Reproductive Medicine in collaboration with The Society of Reproductive Surgeons. Salpingectomy for hydrosalpinges before in vitro fertilization increases the success rate. Fertil Steril. 2008;90:S66–8.

    Google Scholar 

  35. Alper MM, Garner PR, Spence JE, et al. Pregnancy rates after hysterosalpingography with oil- and water-soluble contrast media. Obstet Gynecol. 1986;68:6–9.

    PubMed  CAS  Google Scholar 

  36. Galen DI, Khan N, Richter KS. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J Minim Invasive Gynecol. 2011;18(3):338–42.

    Article  PubMed  Google Scholar 

  37. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.

    Article  Google Scholar 

  38. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005;90(1):581–7.

    Article  PubMed  CAS  Google Scholar 

  39. Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, Reindollar RH. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril. 2005;84(2):435–45.

    Article  PubMed  Google Scholar 

  40. Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360(3):236–43.

    Article  PubMed  CAS  Google Scholar 

  41. The Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee of the American Society for Reproductive Medicine. Guidelines on the number of embryos transferred. Fertil Steril. 2008;90:S163–4.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael M. Alper M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nguyen, KH., Alper, M.M. (2012). Pre IVF Evaluation of the Infertile Woman. In: Ginsburg, E., Racowsky, C. (eds) In Vitro Fertilization. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9848-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9848-4_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9847-7

  • Online ISBN: 978-1-4419-9848-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics